Evidence map›Paper›PMID 41876840›Full record

ArticleScientific reports2026

Temporal Learning with Dynamic Range (TLDR) for modeling recurrent exposure and treatment outcomes.

Jingya Cheng, Jonas Hügel, Jiazi Tian, Alaleh Azhir, Shawn N Murphy, Jeffrey G Klann, Hossein Estiri

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Jingya Cheng *Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Jonas Hügel *Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Jiazi TianDepartment of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Alaleh AzhirDepartment of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Shawn N MurphyDepartment of Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, USA.
Jeffrey G KlannDepartment of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Hossein EstiriDepartment of Medicine, Massachusetts General Hospital, Boston, MA, USA. hestiri@mgh.harvard.edu.

Funding

Temporal Phenotypes and Risk Models for the Post-COVID Syndrome and its sub-typesR01AI165535 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Hossein Estiri, SHAWN N MURPHY · 2022 to 2026
$4.1M
DAAD IFI, BMBF, DFG 426671079National Institute of Allergy and Infectious Diseases R01AI165535NIAID NIH HHS R01 AI165535
6 · The paper itself

Abstract

The temporal sequence of clinical events is crucial in outcomes research, yet standard machine learning (ML) approaches often overlook this aspect in electronic health records (EHRs), limiting predictive accuracy. We introduce Temporal Learning with Dynamic Range (TLDR), a time-sensitive ML framework, to identify risk factors for post-acute sequelae of SARS-CoV-2 infection (PASC). Using longitudinal EHR data from over 85,000 patients in the Precision PASC Research Cohort (P2RC) from a large integrated academic medical center, we compare TLDR against a conventional atemporal ML model. TLDR demonstrated superior predictive performance, achieving a mean AUROC of 0.791 compared to 0.668 for the benchmark, marking an 18.4% improvement. Additionally, TLDR's mean PRAUC of 0.590 significantly outperformed the benchmark's 0.421, a 40.14% increase. The framework exhibited improved generalizability with a lower mean overfitting index (- 0.028), highlighting its robustness. Beyond predictive gains, TLDR's use of time-stamped features enhanced interpretability, offering a more precise characterization of individual patient records. TLDR effectively captures exposure-outcome associations and offers flexibility in time-stamping strategies to suit diverse clinical research needs. TLDR provides a simple yet effective approach for integrating dynamic temporal windows into predictive modeling. It is available within the MLHO R package to support further exploration of recurrent treatment and exposure patterns in various clinical settings.

Indexed as

COVID-19Machine LearningElectronic Health RecordsHumansPredictive Learning ModelsRisk FactorsSARS-CoV-2Treatment Outcome

Identifiers

PMID41876840
PMCPMC13168663

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.